Inmune Bio Inc.
INMB· Nasdaq
Released Nov 8, 2019, after the close
10-Q filed Nov 8, 2019, 39 days after period end · 0001213900-19-022556
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Net Income | -$3.07M | -$1.54M |
| EPS Diluted | -$0.28 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inmune Bio Inc. · CIK 1711754 · Engraved from SEC EDGAR